Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wade J Sexton

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
The Journal of Urology|January 22, 2010
Editorial commentWade J Sexton
Urology|April 24, 2013
Editorial commentWade J Sexton
Cancer Control : Journal of the Moffitt Cancer Center|August 4, 2006
Management of locally advanced renal cell carcinomaAlejandro Rodriguez, Wade J Sexton
The Journal of Urology|January 19, 2024
Editorial CommentJoshua A Linscott, Wade J Sexton
Translational Andrology and Urology|February 15, 2020
Focused issue on testicular cancer-forwardWade J Sexton, Scott M Gilbert
The Journal of Urology|May 18, 2018
Re: Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence: B. Kiss, M. A. Furrer, P. Y. Wuethrich, F. C. Burkhard, G. N. Thalmann and B. Roth J Urol 2017;198:1263-1268Kamran Zargar-Shoshtari, Wade J Sexton
Nature Reviews. Urology|August 17, 2011
Bladder cancer: validating the EORTC risk tables in BCG-treated patientsDavid D Buethe, Wade J Sexton
The Journal of Urology|September 27, 2023
Primary Chemoablation for Intermediate-risk Low-grade Bladder Cancer: New Paradigm or Added Uncertainty?Prithvi B Murthy, Wade J Sexton
The Journal of Urology|May 2, 2022
Real-World Outcomes Driving the Needle toward Simplification of Nonmuscle Invasive Bladder Cancer Risk StratificationHeather L Huelster, Wade J Sexton
European Urology Focus|October 1, 2019
Optimal Management of High-risk Stage I Nonseminoma Germ Cell Tumor: Active Intervention is the Preferred OptionScott M Gilbert, Wade J Sexton
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
The Journal of Urology|January 22, 2010
Editorial commentWade J Sexton
Urology|April 24, 2013
Editorial commentWade J Sexton
Cancer Control : Journal of the Moffitt Cancer Center|August 4, 2006
Management of locally advanced renal cell carcinomaAlejandro Rodriguez, Wade J Sexton
The Journal of Urology|January 19, 2024
Editorial CommentJoshua A Linscott, Wade J Sexton
Translational Andrology and Urology|February 15, 2020
Focused issue on testicular cancer-forwardWade J Sexton, Scott M Gilbert
The Journal of Urology|May 18, 2018
Re: Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence: B. Kiss, M. A. Furrer, P. Y. Wuethrich, F. C. Burkhard, G. N. Thalmann and B. Roth J Urol 2017;198:1263-1268Kamran Zargar-Shoshtari, Wade J Sexton
Nature Reviews. Urology|August 17, 2011
Bladder cancer: validating the EORTC risk tables in BCG-treated patientsDavid D Buethe, Wade J Sexton
The Journal of Urology|September 27, 2023
Primary Chemoablation for Intermediate-risk Low-grade Bladder Cancer: New Paradigm or Added Uncertainty?Prithvi B Murthy, Wade J Sexton
The Journal of Urology|May 2, 2022
Real-World Outcomes Driving the Needle toward Simplification of Nonmuscle Invasive Bladder Cancer Risk StratificationHeather L Huelster, Wade J Sexton
European Urology Focus|October 1, 2019
Optimal Management of High-risk Stage I Nonseminoma Germ Cell Tumor: Active Intervention is the Preferred OptionScott M Gilbert, Wade J Sexton
Pageof 18